Complement factor H protects tumor cell-derived exosomes from complement-dependent lysis and phagocytosis. by Ryan T Bushey, Elizabeth B Gottlin, Michael J Campa, Edward F Patz

Get full text

Enhanced CDC of B cell chronic lymphocytic leukemia cells mediated by rituximab combined with a novel anti-complement factor H antibody. by Mark T Winkler, Ryan T Bushey, Elizabeth B Gottlin, Michael J Campa, Eross S Guadalupe, Alicia D Volkheimer, J Brice Weinberg, Edward F Patz

Get full text

Complement factor H: a novel innate immune checkpoint in cancer immunotherapy by Ruchi Saxena, Elizabeth B. Gottlin, Michael J. Campa, Ryan T. Bushey, Jian Guo, Edward F. Patz, Edward F. Patz, You-Wen He

Get full text

A Therapeutic Antibody for Cancer, Derived from Single Human B Cells by Ryan T. Bushey, M. Anthony Moody, Nathan L. Nicely, Barton F. Haynes, S. Munir Alam, Stephen T. Keir, Rex C. Bentley, Kingshuk Roy Choudhury, Elizabeth B. Gottlin, Michael J. Campa, Hua-Xin Liao, Edward F. Patz, Jr.

Get full text

Upregulation of complement proteins in lung cancer cells mediates tumor progression by Emily K. Kleczko, Joanna M. Poczobutt, Andre C. Navarro, Jennifer Laskowski, Amber M. Johnson, Sean P. Korpela, Natalia J. Gurule, Lynn E. Heasley, Katharina Hopp, Mary C.M. Weiser-Evans, Elizabeth B. Gottlin, Ryan T. Bushey, Michael J. Campa, Edward F. Patz, Edward F. Patz, Joshua M. Thurman, Raphael A. Nemenoff

Get full text